Literature DB >> 8394145

Transient lupus anticoagulant associated with hypoprothrombinemia and factor XII deficiency following adenovirus infection.

U Jaeger1, S Kapiotis, I Pabinger, E Puchhammer, P A Kyrle, K Lechner.   

Abstract

A potent lupus anticoagulant (LA) was detected in four children, 1 week after the clinical onset of an adenovirus infection. The adenovirus infection was documented by direct virus detection in the stool of one patient and serologically in the others. None of the children had elevated titers of IgM- and only one of IgG-anticardiolipin antibodies (ACA). All patients had a marked reduction of prothrombin activity as well as antigen. Prothrombin-antibody complexes were demonstrated in the patients' plasma or mixtures of patient and normal plasma. Factor XII activity was moderately reduced in three of the patients. All coagulation abnormalities returned to normal within 4-12 weeks. Localized bleeding was observed in two cases, but there was no generalized bleeding tendency or evidence of thrombosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394145     DOI: 10.1007/bf01788133

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  18 in total

1.  Anticardiolipin antibodies in leptospirosis.

Authors:  F P Rugman; G Pinn; M F Palmer; M Waite; C R Hay
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

2.  A clinical study of the lupus anticoagulant.

Authors:  M A Schleider; R L Nachman; E A Jaffe; M Coleman
Journal:  Blood       Date:  1976-10       Impact factor: 22.113

3.  Anti-cardiolipin antibodies in viral infection.

Authors:  C B Colaço; I J Mackie; W Irving; S J Machin
Journal:  Lancet       Date:  1989-03-18       Impact factor: 79.321

4.  Anti-prothrombin antibodies and the lupus anticoagulant.

Authors:  R A Fleck; S I Rapaport; L V Rao
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

Review 5.  Acquired inhibitors in nonhemophilic patients.

Authors:  K Lechner
Journal:  Haemostasis       Date:  1974

6.  A new type of coagulation inhibitor.

Authors:  K Lechner
Journal:  Thromb Diath Haemorrh       Date:  1969-06-15

7.  Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature.

Authors:  K Lechner; I Pabinger-Fasching
Journal:  Haemostasis       Date:  1985

8.  Acquired inhibitors of coagulation in nonhemophiliac children.

Authors:  G M Brodeur; P J O'Neill; J A Willimas
Journal:  J Pediatr       Date:  1980-03       Impact factor: 4.406

9.  The lupus anticoagulant.

Authors:  M Boxer; L Ellman; A Carvalho
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec

10.  A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome.

Authors:  S P Bajaj; S I Rapaport; D S Fierer; K D Herbst; D B Schwartz
Journal:  Blood       Date:  1983-04       Impact factor: 22.113

View more
  6 in total

1.  Biodistribution and toxicological safety of adenovirus type 5 and type 35 vectored vaccines against human immunodeficiency virus-1 (HIV-1), Ebola, or Marburg are similar despite differing adenovirus serotype vector, manufacturer's construct, or gene inserts.

Authors:  Rebecca L Sheets; Judith Stein; Robert T Bailer; Richard A Koup; Charla Andrews; Martha Nason; Bin He; Edward Koo; Holly Trotter; Chris Duffy; T Scott Manetz; Phillip Gomez
Journal:  J Immunotoxicol       Date:  2008-07       Impact factor: 3.000

2.  Lupus anticoagulants in two children--bleeding due to nonphospholipid-dependent antiprothrombin antibodies.

Authors:  Karin Knobe; Ulf Tedgård; Torben Ek; Per-Erik Sandström; Andreas Hillarp
Journal:  Eur J Pediatr       Date:  2012-04-19       Impact factor: 3.183

Review 3.  Transient antiphospholipid antibodies associated with acute infections in children: a report of three cases and a review of the literature.

Authors:  H Mizumoto; T Maihara; E Hiejima; M Shiota; A Hata; S Seto; T Atsumi; T Koike; D Hata
Journal:  Eur J Pediatr       Date:  2006-03-22       Impact factor: 3.183

4.  Acquired factor XII deficiency in a woman with recurrent pregnancy loss: working on a differential diagnosis in a single case.

Authors:  Maristella D'Uva; Ida Strina; Antonio Mollo; Antonio Ranieri; G De Placido; P Di Micco
Journal:  J Transl Med       Date:  2005-12-02       Impact factor: 5.531

5.  Successful Treatment of Life-threatening Bleeding Caused by Acquired Factor X Deficiency Associated with Respiratory Infection.

Authors:  Satoshi Ichikawa; Kei Saito; Noriko Fukuhara; Yuya Tanaka; Yoonha Lee; Koichi Onodera; Yasushi Onishi; Hisayuki Yokoyama; Minami Fujiwara; Hideo Harigae
Journal:  Intern Med       Date:  2020-02-05       Impact factor: 1.271

6.  Nonclinical safety assessment of repeated administration and biodistribution of ChAd3-EBO-Z Ebola candidate vaccine.

Authors:  Camille Planty; Guillaume Chevalier; Marie-Ève Duclos; Clémentine Chalmey; Catherine Thirion-Delalande; Cécile Sobry; Ann-Muriel Steff; Eric Destexhe
Journal:  J Appl Toxicol       Date:  2020-01-21       Impact factor: 3.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.